138 related articles for article (PubMed ID: 15492320)
1. Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.
Pidgeon GP; Tamosiuniene R; Chen G; Leonard I; Belton O; Bradford A; Fitzgerald DJ
Circulation; 2004 Oct; 110(17):2701-7. PubMed ID: 15492320
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2-linked attenuation of hypoxia-induced pulmonary hypertension and intravascular thrombosis.
Cathcart MC; Tamosiuniene R; Chen G; Neilan TG; Bradford A; O'Byrne KJ; Fitzgerald DJ; Pidgeon GP
J Pharmacol Exp Ther; 2008 Jul; 326(1):51-8. PubMed ID: 18375790
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.
Dowd NP; Scully M; Adderley SR; Cunningham AJ; Fitzgerald DJ
J Clin Invest; 2001 Aug; 108(4):585-90. PubMed ID: 11518732
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
Belton OA; Duffy A; Toomey S; Fitzgerald DJ
Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension.
Widlansky ME; Price DT; Gokce N; Eberhardt RT; Duffy SJ; Holbrook M; Maxwell C; Palmisano J; Keaney JF; Morrow JD; Vita JA
Hypertension; 2003 Sep; 42(3):310-5. PubMed ID: 12874094
[TBL] [Abstract][Full Text] [Related]
6. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
[TBL] [Abstract][Full Text] [Related]
7. Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds.
Baber SR; Champion HC; Bivalacqua TJ; Hyman AL; Kadowitz PJ
Circulation; 2003 Aug; 108(7):896-901. PubMed ID: 12900348
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn pigs.
Fike CD; Kaplowitz MR; Zhang Y; Pfister SL
J Appl Physiol (1985); 2005 Mar; 98(3):1111-8; discussion 1091. PubMed ID: 15516370
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension.
Cheng HF; Wang CJ; Moeckel GW; Zhang MZ; McKanna JA; Harris RC
Kidney Int; 2002 Sep; 62(3):929-39. PubMed ID: 12164875
[TBL] [Abstract][Full Text] [Related]
10. Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats.
Su CL; Yuan DW; Chiang LL; Lee HL; Chen KH; Wang D
Transplant Proc; 2012 May; 44(4):929-32. PubMed ID: 22564588
[TBL] [Abstract][Full Text] [Related]
11. Selective cyclooxygenase-2 inhibition by nimesulide in man.
Cullen L; Kelly L; Connor SO; Fitzgerald DJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
[TBL] [Abstract][Full Text] [Related]
14. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
[TBL] [Abstract][Full Text] [Related]
15. Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers.
McAdam BF; Byrne D; Morrow JD; Oates JA
Circulation; 2005 Aug; 112(7):1024-9. PubMed ID: 16087791
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat.
Li RC; Row BW; Gozal E; Kheirandish L; Fan Q; Brittian KR; Guo SZ; Sachleben LR; Gozal D
Am J Respir Crit Care Med; 2003 Aug; 168(4):469-75. PubMed ID: 12773326
[TBL] [Abstract][Full Text] [Related]
17. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells.
Kohlstedt K; Busse R; Fleming I
Hypertension; 2005 Jan; 45(1):126-32. PubMed ID: 15569856
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs.
Fike CD; Kaplowitz MR; Pfister SL
Am J Physiol Lung Cell Mol Physiol; 2003 Feb; 284(2):L316-23. PubMed ID: 12388340
[TBL] [Abstract][Full Text] [Related]
19. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G
Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
